MARKSANS PHARMA
Back to Cashflow Statement
|
MARKSANS PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹198 Cr | ₹80 Cr | ₹-15 Cr | ₹-114 Cr | ₹-21 Cr |
What is the latest Cash Flow from Financing Activities ratio of MARKSANS PHARMA ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2023 | ₹198 Cr |
Mar2022 | ₹80 Cr |
Mar2021 | ₹-15 Cr |
Mar2020 | ₹-114 Cr |
Mar2019 | ₹-21 Cr |
How is Cash Flow from Financing Activities of MARKSANS PHARMA Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2023 | ₹198 Cr | 148.81 | |
Mar2022 | ₹80 Cr | Positive | |
Mar2021 | ₹-15 Cr | Negative | |
Mar2020 | ₹-114 Cr | Negative | |
Mar2019 | ₹-21 Cr | - |
Compare Cash Flow from Financing Activities of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹7,532.2 Cr | -3.5% | 5.3% | 107.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
CIPLA | ₹115,034.0 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | -3.5% |
5.3% |
107.5% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses